Conference Abstract
 
Navigation
Conference Abstracts Index

Abstracts - 2006 London

Abstracts - 2005 Zurich

Abstracts - 2004 Berlin

Abstracts - 2003 Barcelona

Abstracts - 2002 Brussels

Abstracts - 2001 Tokyo

Abstracts - 2000 Marburg

       

L12.    Oral ciclosporin in lichen planopilaris.
Pascal Reygagne, Philippe Assouly, Bruno Matard, Cindy Lyonnet, Corinne Jouanique; Centre Sabouraud, Hopital Saint-Louis, 1 Avenue Claude Vellefaux, 75010, Paris, France.

Lichen planopilaris (LPP) is a rare inflammatory disease that causes permanent alopecia. When the disease is very active the best treatment is oral corticotherapy, but relapse is frequent. A short course of oral cyclosporine has been reported successful in treating 3 patients. We present 12 patients with refractory LPP treated for 3 to 7 months with cyclosporine. They were aged from 31 to 59 years with a diagnosis of LPP from 1 to 19 years. Previous treatment included topical and intralesional corticosteroids, hydroxychloroquine, chloroquine, topical tacrolimus and oral corticotherapy (n=5). At the beginning of the study, the dosage of cyclosporine was 3mg/kg/Day, increased monthly in case of non-response. Treatment was stopped after 2 months without symptoms. In a few patients we measured hair density on a selected target and performed global standardized photography. We obtained complete clinical resolution of the disease activity at doses ranging from 250mg to 400mg, and treatment duration of 4 to 8 months. A complete clinical response was achieved in 8 patients and a partial response in 2. Two patients failed to respond. Six months after stopping cyclosporine 6 patients remained symptom free and 4 had relapsed. Hair count was available before and after treatment for 9 patients with stabilisation (n=4), increase (n=3) or decrease (n=2). The two patients with a decrease were clinically rated failure or partial response. Side effects were minor: these included transient elevation of serum creatinine (n=4), distal paresthesia (4), and hypertrichosis (2).

On the basis of this experience:
- Cyclosporine can be an option to treat refractory LPP
- Optimal efficient dosage is between 4 and 5 mg/kg/day
- Optimal course is 4 months
- Success rate is 83%
- Relapse rate 6 months after stopping the course is 40%
- A study versus systemic oral corticotherapy is necessary